Navigation Links
MiMedx Announces 2012 Results
Date:3/7/2013

in amniotic membrane tissue processing, we expect to have numerous opportunities to capture additional market presence based on the anticipated results from these studies. In addition, we are rapidly conducting broader clinical evaluations of our AmnioFix® allografts used for surgical procedures and our micronized version of AmnioFix® used for soft tissue injections. To meet these market opportunities, we are continuing to increase the staff in our clinical research area to complete these studies on an aggressive timetable." 

Bill Taylor, President and COO, commented, "The  results we expect from our clinical studies will further validate the clinical and cost effectiveness of our EpiFix® and AmnioFix® allografts. With the publication of these studies, we expect to see reimbursement coverage broaden among commercial health insurance plans and Medicare intermediaries. The various Medicare intermediaries generally do not reimburse products in this category without additional clinical data to support their efficacy; however, based on the impressive results for the studies to date, we have received positive notification from five of the nine intermediaries."

Last month, the Company announced that the U.S. Patent and Trademark Office issued four new patents to MiMedx related to its placental-based allografts, bringing the Company's total patent coverage to five U.S. patents.  "We expect at least one more placental- based patent to be issued over the next two months.  We currently have a total of 24 pending patent applications relating to our proprietary AmnioFix® and EpiFix® technologies and our placental tissue allografts. Our strategy has been to patent the key elements of our Purion® Process, as well as the resulting EpiFix® and AmnioFix® graft configurations.  In addition, we are developing several patent applications around our base patents to build a barrier around our key intelle
'/>"/>

SOURCE MiMedx Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. MiMedx Group to Present at the 6th Annual OneMedForum
2. MiMedx Group to Present at the Stifel Nicolaus 2012 Healthcare Conference
3. CCS Medical Announces Agreement with LifeScan
4. HUYA Bioscience Announces Partnership With Shanghai Zhangjiang Biotech Pharmaceutical Base
5. AVANIR PHARMACEUTICALS ANNOUNCES RESEARCH COLLABORATION WITH DEPARTMENT OF VETERANS AFFAIRS FOR SCREENING PSEUDOBULBAR AFFECT (PBA) SYMPTOMS IN VETERANS WITH TRAUMATIC BRAIN INJURY
6. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Impax Laboratories Inc.
7. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
8. DMH International Announces The Launch of TouchPACS
9. Psyche Systems Announces Availability of Toxicology LIS
10. Jazz Pharmaceuticals Announces Pricing Of Public Offering Of Ordinary Shares By Selling Shareholders
11. DDS Lab Announces Strategic Alliance with United Concordia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... England , July 2, 2015 ... known as ,Friendly Aedes aegypti , , ... Juazeiro, Brazil by 95%, well ...      (Logo: http://photos.prnewswire.com/prnh/20150630/227348LOGO) , The journal ... a trial of Oxitec,s genetically engineered mosquitoes. The results ...
(Date:7/2/2015)... 2015 According to a new market ... Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation), Application (Depression, Parkinson,s, ... 2020", published by MarketsandMarkets, the global Neuromodulation Market is estimated ... $6.20 Billion by 2020, at a CAGR of 11.2% during ... 4 market data T ables and ...
(Date:7/2/2015)... June 25, 2015 Research and Markets( ... Market by Technology, Imaging and by Application - Forecast to 2020" ... market is expected to reach $13.1 Billion in 2020 from an ... The market is dominated by North America ... Asia , and Rest of the World (RoW). The cancer ...
Breaking Medicine Technology:Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3Neuromodulation Market Worth $6.20 Billion by 2020 2Neuromodulation Market Worth $6.20 Billion by 2020 3Neuromodulation Market Worth $6.20 Billion by 2020 4Global Cancer Diagnostics Market Report 2015 - Technology, Imaging and by Applications Forecasts to 2020 for the $13 Billion Industry 2
... , April 26 Body ... for the Apple iPhone, is now available on the new iPad ... of its kind to help people live healthier lifestyles by showing ... things can help them eat better, sleep better and handle stress ...
... TAMPA, Fla. , April 26 Sirion ... that Zirgan™ (ganciclovir ophthalmic gel) 0.15% is now commercially available. ... Administration in September 2009 , is a topical ophthalmic ... ulcers).   , , ...
Cached Medicine Technology:Heal Your 'Body & Mind' on the iPad, Too! 2Heal Your 'Body & Mind' on the iPad, Too! 3Sirion Therapeutics Announces Availability of Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% for Ocular Herpes 2Sirion Therapeutics Announces Availability of Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% for Ocular Herpes 3
(Date:7/4/2015)... ... 04, 2015 , ... Tyler Boden, Project Developer of Sullivan ... from the North American Board of Certified Energy Practitioners (NABCEP®), and is now ... and well established national certification organization for renewable energy professionals. Designation as a ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Scientists at ... susceptible to mesothelioma with even minimal asbestos exposure. Click here to read the ... the University of Hawaii Cancer Center, Cedars Sinai Medical Center, and New York University ...
(Date:7/3/2015)... Orange, CT (PRWEB) , ... July 03, 2015 , ... ... at home is a good blender and easily accessible, quality ingredients. Aurora Natural is ... your smoothie for an added boost of fiber, protein, antioxidants, vitamins and minerals! , ...
(Date:7/3/2015)... ... July 03, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The ... he says will reveal biblical truth and expose popular lies regarding proper relationships according ... Don’t Have Sex”, immediately goes into the core of the subject by explaining why ...
(Date:7/2/2015)... , ... July 02, 2015 , ... sweetFrog Enterprises, LLC. ... opening is now the 19th sweetFrog store located in the Lone Star State. The ... fastest growing companies in 2014. , The store, which opened July 1 at Duke’s ...
Breaking Medicine News(10 mins):Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2
... , , , , , ... , , AUDIO: ... cancer... , Click here for more information. , ... , , , , , ...
... that looked at the hunger trends over a 10-year period ... more than one in seven, face the threat of hunger. ... reported that one in nine seniors faced the threat of ... agricultural and consumer economics and executive director of the National ...
... HealthDay Reporter , MONDAY, May 14 (HealthDay News) ... less likely to continue their education or get a job ... disabilities, new research indicates. According to the study, only ... and only 55 percent had a job during the first ...
... May 14 (HealthDay News) -- The multiple sclerosis drug ... certain pre-existing or recent heart conditions or stroke, or ... says a U.S. Food and Drug Administration safety announcement ... of a report of a patient who died within ...
... (San Antonio)Nice guys do finish last at least when it ... of Texas at San Antonio that answers the question of ... assistant professor of marketing at The University of Texas at ... with ovulation influence women,s perceptions of men as potential fathers. ...
... has identified microRNA-3151 as a new independent prognostic marker ... patients with acute myeloid leukemia and normal-looking chromosomes ,(CN-AML). ... University Comprehensive Cancer Center Arthur G. James Cancer ... James) found that when microRNA-3151 (miR-3151) is overexpressed in ...
Cached Medicine News:Health News:Genetic test identifies eye cancer tumors likely to spread 2Health News:Genetic test identifies eye cancer tumors likely to spread 3Health News:Genetic test identifies eye cancer tumors likely to spread 4Health News:Genetic test identifies eye cancer tumors likely to spread 5Health News:Great recession reflux amounts to more hunger among seniors 2Health News:Employment Prospects Dim for Young Adults With Autism 2Health News:Employment Prospects Dim for Young Adults With Autism 3Health News:FDA Issues Multiple Sclerosis Drug Alert 2Health News:UTSA study finds ovulating women perceive sexy cads as good dads 2Health News:A microRNA prognostic marker identified in acute leukemia 2
... 2200 system is a fully automated ... deliver up to 2200 results per ... a panel of assays targeting autoimmune ... in the areas of serology, infectious ...
... ASR contains primers and a FAM-labeled probe targeting ... as well as primers and an Alexa 532-labeled ... of HSV Type 2. This ASR requires an ... Alexa reporter dyes like the Cepheid SmartCycler System. ...
... The HSV Non-Typing ASR contains primers and a ... 92 bp region of the HSV Type 1 ... an instrument that can detect a FAM reporter ... Cepheid Analyte Specific Reagent* (ASR) program is comprised ...
... Stratus CS Analyzer, designed for Acute Care Diagnostics, ... laboratory and near patient setting. It's a random ... D-Dimer results from a whole blood sample in ... step process load sample and rotor, load ...
Medicine Products: